« Previous
Next »
American Heart Journal
Volume 152, Issue 3
, Pages 454.e1-454.e8
, September 2006
National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance
References
- . Heart Disease and Stroke Statistics—2006 Update. Published online before print January 11, 2006. Available online at: http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.105.171600v1.pdf
- Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–371
- . Overview of results of randomized clinical trials in heart disease: I. Treatments following myocardial infarction. JAMA. 1988;260:2088–2093
- Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730–1737
- . Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–1390
- Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115–121
- National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280:623–629
- . Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications. Pharmacoeconomics. 1999;15:257–268
- Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) initiative. JAMA. 2002;287:1269–1276
- Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004;164:203–209
- JCAHO Website. Available at: http://www.jcaho.org/quality+check/index.htm. Accessed January 27, 2006.
- . The State of Health Care Quality: 2003. Available at: http://www.ncqa.org/communications/State%20Of%20Managed%20Care/SOHCREPORT2003.pdf[Accessed January 27, 2006]
- Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol. 2002;40:1589–1595
- Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J. 2003;145:438–444
- Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73–81
- . Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med. 1985;313:1055–1058
- . The prescription-drug problem. N Engl J Med. 2002;346:790
- Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952–960
- . HEDIS 2004 Final NDC Lists. Available at: http://www.ncqa.org/Programs/HEDIS/legal2004.htm[Accessed January 27, 2006]
- Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455–461
- . The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA. 1993;270:742–744
- . Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462–467
- . Organizing care for patients with chronic illness. Milbank Q. 1996;74:511–544
- . Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868–2879
- . Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163:1461–1466
- Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med. 2001;134:173–181
- American Heart Association website. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3017091. Accessed January 27, 2006.
- National Heart Lung and Blood Institute website. Available at: http://www.nhlbi.nih.gov/health/hearttruth/. Accessed January 27, 2006.
- . Medicare + Choice plans continue to shift more costs to enrollees. April 2003. Available at: http://www.cmwf.org/usr_doc/achman_m+cshiftcosts_628.pdf[Accessed January 27, 2006]
- Council for Affordable Quality Healthcare website. Available at: http://www.caqh.org/life.html. Accessed January 27, 2006.
- . From motives to results: improving the effectiveness of quality improvement. Am J Med. 2004;117:359–361
Duke investigators are supported in part by grant HS010548 from the Agency for Healthcare Research and Quality, Rockville, Md.
Funding/Support: Participating health plans contributed personnel time for work groups (listed in Appendix B) and for collection and reporting of data. The Council for Affordable Quality Healthcare (CAQH) contracted with PricewaterhouseCoopers to aggregate de-identified data submitted by health plans and to provide feedback to the plans on the quality of data. The CAQH also provided an honorarium to Duke University for its investigators' time in analyzing and interpreting the aggregated data and preparing the manuscript.
Role of the Sponsor: CAQH provided a project manager to support the CAQH Cardiac and Measurement Work Groups. Final decisions on study design and technical specifications were made by the CAQH Cardiac and Measurement Work Groups. The CAQH allowed Duke investigators full independence in the analysis and interpretation of the data. The manuscript was prepared by Duke investigators. Contributing authors provided review and approval.
Guest editor of this manuscript is Deepak L. Bhatt, MD.
PII: S0002-8703(06)00169-4
doi: 10.1016/j.ahj.2006.02.030
© 2006 Mosby, Inc. All rights reserved.
« Previous
Next »
American Heart Journal
Volume 152, Issue 3
, Pages 454.e1-454.e8
, September 2006
